A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Clinical trial NCT01996826 · COMPLETED
Trial details
- NCT number
- NCT01996826
- Sponsor
- Reza Dana, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2019-04-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.